申请人:KINNATE BIOPHARMA INC
公开号:WO2020198058A1
公开(公告)日:2020-10-01
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
本文提供了受体酪氨酸激酶效应子RAF的抑制剂,包括所述化合物的药物组合物,以及使用这些化合物治疗疾病的方法。